Category: Industry News

Certified Excellence: ASC Associates Ltd Pioneers GDP Program for Pharmaceutical Logistics in Partnership with PCSC

New Jersey, USA, 4th April 2024 – ASC Associates Ltd, a leading provider of supply chain solutions, is thrilled to announce the launch of its highly anticipated Good Distribution Practice (GDP) Program. This innovative initiative, developed in collaboration with the HDA’s Pharmaceutical Cargo Security Coalition (PCSC), marks a significant milestone in enhancing supply chain integrity and efficiency within the pharmaceutical industry. The program is designed to strengthen the integrity of the pharmaceutical supply chain and set new industry standards. ASC Associates Ltd, a trusted name in GDP program design and training, is the driving force behind this accreditation, ensuring that participants meet recognized operational and training criteria.

The GDP Accreditation was unveiled at the HDA’s PCSC Educational Seminar in Whippany, N.J., on 4th April 2024. It offers a comprehensive assessment process that aligns with European standards and endorsed criteria from the PCSC. Companies that complete the rigorous training phase receive accreditation that is valid for two years, with an option for renewal, ensuring ongoing compliance and proficiency.

DeSpir Logistics, a leading 3PL Logistics Provider, has not only completed the program but has also become the first recipient of the accreditation. This remarkable achievement serves as a beacon of inspiration, demonstrating the efficacy of the program in aligning existing supply chain security and quality best practices.

“GDP Accreditation” is a groundbreaking initiative that is poised to transform the transportation and logistics sector in the United States. This program offers companies a unique opportunity to improve their supply chain practices, which can significantly enhance their operations and service offerings. According to Amy Shortman, the Founder and EVP of Product Marketing at ASC, pharmaceutical companies require high trust when entrusting valuable cargo to a transportation company. As a result, they tend to prefer working with logistics partners that adhere to the best supply chain compliance and security practices and have been certified by an independent entity. Extending the pharmaceutical companies’ quality standards downstream to logistics partners, creates an invaluable system of trust and efficiency in the industry.

Henry Moran, COO of ASC Associates Ltd and advisory board member of PCSC, praised the collaborative effort behind the program’s development and its potential to enhance supply chain resilience. Moran commended DeSpir Logistics for its pioneering role and highlighted the programme’s broader impact on industry stakeholders.

ASC Associates Ltd’s GDP Program offers unparalleled training and accreditation for companies seeking to elevate their supply chain practices and safeguard product quality and integrity. For more information, please visit hda-and-pcsc-announce-launch-of-gdp-accreditation-program.

White Paper: Passive vs. Active Systems in a globally disrupted age

With the ever-growing demand for cold chain distribution, compounded by the COVID-19 pandemic, ASC Associates in partnership with Tower Cold Chain Solutions have co-authored a white paper that explores the Active, Passive and Hybrid Temperature Controlled Packaging options.


With the support of 10 industry leaders the white paper provides a non biased review of this developing market along with practical advice on where and when temperature-controlled packaging should be used in a global pharmaceutical supply chain.

A link to the white paper is here

Leading Minds Network Series

ASC Associates are pleased to be supporting the upcoming Leading Minds Network Series.  Henry Moran, will be facilitating two sessions on 22nd February and 1st March.

In the session on 22nd February we will be looking at the topic of Product Integrity and exploring the challenges the industry faces with respect to Global Distribution.  We look to answers questions in regards product security, temperature management, product visibility and the increasing regulatory requirements. Details of the session can be found here:

Maintaining Product Integrity in a Global Supply Chain

On the 1st March, our discussions will be about end to end visibility and risk management.  We will be discussing how we can use technology to reduce risk, across a supply chain increasingly global in nature.

Risk-based Logistics for End-To-End Supply Chain Visibility

For full details on all of the “Temperature Controlled Tuesdays” sessions please click here

The Leading Minds Network is a community that seeks to foster innovation, honest discussions, ideas and best practices, so that the collective experiences of the community can be shared for the greater good. Members shares stories with industry peers who are implementing solutions today, overcoming regulatory hurdles or operational roadblocks, even organizational changes.




ASC Associates partners with Biomap to enhance its Temperature Compliance Services

CAMBRIDGE, UK and LONDON, UK, March 16th, 2021. ASC Associates, a bespoke auditing, training and consultancy organisation specialising in GDP and Supply Chain Security compliance, announces it has signed a partnership with Biomap, a leading service provider to the Life Sciences industry of temperature mapping and temperature monitoring compliant systems.

By working in partnership, ASC has expanded its programme of auditing, training and consultancy, to now include validation activities and systems to support clients with their regulatory demands.

Kane Edgeworth, Commercial Director of Biomap commented; “‘Biomap are delighted to announce this new partnership with ASC Associates.  ASC’s expertise in GDP compliance is a great fit to Biomaps existing portfolio of validation solutions. We very much look forward to offering our clients this new package of services to support their GDP licensing and compliance demands’

Henry Moran, Director of ASC Associates said: “ ASC’s new partnership with Biomap creates a powerful alliance, aligning our areas of expertise and resources. Biomaps deep history brings close to two decades of experience and knowledge and offers a full suite of validation services with a particular specialism in temperature compliance within storage and distribution environments”

About ASC

ASC Associates are a bespoke consultancy, training and auditing organisation providing services to the Life Science and Pharmaceutical supply chain. In the high-value, pharmaceutical and healthcare worlds – where threats to product safety and security are ever-increasing, ASC are dedicated to improving all aspects of supply chain logistics.  With a relentless focus on innovation, security, safety, compliance and efficacy.

For more information visit ASC or LinkedIn

About Biomap

Based in Park Royal, West London, Biomap works exclusively in the Life Sciences industry providing a wide range of products and services specifically designed to fit with industry regulation.

Biomap has extensive experience of working with the World’s largest Pharmaceutical Companies, implementing multi-level Route Qualification and Temperature Mapping programmes as well as installing fully validated 21CFR Part 11 compliant monitoring systems.

For more information visit Biomap of LinkedIn

A paper on Mapping the Secure Temperature Controlled Supply Chain Requirements for the Journal of Pharmaceutical and Biopharmaceutical Contract Services

Last month our Director, Henry Moran, recently co-authored a paper for the Q4 2020 addition of the Journal of Pharmaceutical & Biopharmaceutical Contract Services, along with Rafik H Bishara Ph.D and Chuck Forsaith. The paper presents a model for mapping secure, temperature controlled, supply chain lanes as well as outlining best practice on supply chain security.

You can read a copy of the full article here Mapping the Secure Temperature Controlled Supply Chain Requirements

No alt text provided for this image

RX360 partner with ASC Associates to offer audit services to the globally recognised Rx360 audit programme.


RX360 partner with ASC Associates to offer audit services to the globally recognised Rx360 audit programme.

Partnership will bring global expertise in Supply Chain Security and Good Distribution Practice to RX360 members.

CAMBRIDGE, UK and PHILADELPHIA, USA, August 3rd, 2020. Rx-360, an international pharmaceutical consortium dedicated to supply chain integrity and patient safety, announces it has signed a partnership with ASC Associates Limited (ASC) a consultancy specialising in Global Supply Chain Security and Compliance. By working in partnership, Rx360 has expanded its programme of audit services available to members. ASC brings extensive knowledge and experience on Global Supply Chain Security and Good Distribution Practice compliance.

Jim Fries, CEO of Rx-360 commented, “Being able to bring choice to our membership when it comes to auditing, is a valuable tool that will continue to drive our goal of reducing industry audit burden. This expansion will also bring added focus to our mission around patient safety”.

Henry Moran, Director of ASC commented, “We are delighted and honoured to be selected as a partner for the Rx360 audit programme. With our extensive audit expertise in Supply Chain Security and Good Distribution Practice, aligned with our knowledge of all supply chain stakeholders and service providers, we look forward to working collaboratively to add value to the RX360 member and to improve global standards”.


About RX360

Rx-360 non-profit international consortium addresses pharmaceutical and medical device supply chain security in relation to public health concerns and patient safety. These issues affect billions of individuals around the world on a daily basis. As supply chains become more global, complex and increasingly vulnerable to adulteration and counterfeiting, Rx-360 has increased its focus on strong partnerships between pharmaceutical manufacturers and suppliers to ensure the integrity of supply chains through on-site auditing.

For more information visit RX360

About ASC

ASC Associates are a bespoke consultancy, training and auditing organisation providing services to the Life Science and Pharmaceutical supply chain. In the high-value, pharmaceutical and healthcare worlds – where threats to product safety and security are ever-increasing, we go above and beyond – dedicated to improving all aspects of supply chain logistics.  With a relentless focus on innovation, security, safety, compliance and efficacy, we take extraordinary care with attention to detail. We advise. We assess. We train. We plan. We audit. We scope. We inspect. We implement. In person.

For more information visit ASC or LinkedIn

Nippon Express receives WDA license at LHR

We are delighted that Nippon Express have received their WDA license from the MHRA for Good Distribution Practice of Medicinal Products for Human Use (2013C/ 343/01).  We have been working in partnership with the Nippon Express London team over the last number of years on their GDP project and thanks to the hard work, diligence and professionalism they successfully gained their license in April.

Achieving a WDA license requires extensive auditing and compliance, which is where ASC provided their consultancy, advisory and audit services.

As part of the GDP project we trained over 50 personnel on our bespoke GDP and RP for logistics courses.

ASC were privileged to work with a very strong project team, led by Julian Strutt, Tia Lewis and Damian Tomlinson, and we offer our congratulations to them.

Julian Strutt – General Manager London Regional Branch – Nippon Express

“After shortlisting several companies we chose ASC as a company we felt comfortable working with and by their professionalism and enthusiastic approach.  They set up a thorough training schedule for our Ops Teams which was engaging and interactive, working on case studies and problem solving in small teams. Their help in completing our GDP QMS was invaluable, ASC were always available for advice as and when needed. After a full pre audit walking us through the QMS with us from start to finish we were thoroughly prepared for our MHRA inspection and were awarded with our GDP WDA Licence in April. I have no hesitation in recommending ASC Associates”.

Henry Moran – Director – ASC Associates

“Working with the team at Nippon Express was a real privilege. Their commitment to the project was fantastic, their willingness to learn aligned with their enthusiasm made this project a complete success.  We look forward to continuing to support them with their ongoing training needs. We wish them success on their Life Science service offerings”.

Cold Chain Federation Webinar


ASC Associates had the great opportunity of speaking with Shane Brennan chairman of the Cold Chain Federation on pharmaceutical logistics. The session, a live webinar, focussed on what the food supply chain can learn about compliance and quality from the pharmaceutical industry.  We spoke extensively about Good Distribution Practice and how the principles can be applied in a different market sector.  The webinar is available here


Change is afoot.

9 years ago, I set up ASC. It was born out of a love of working within logistics, combined with the flexibility to be able to care for three little humans that my husband and I had brought into the world.

It has been an amazing journey with some great clients. My husband Henry Moran joined my venture in 2015 and we have worked together for the past 4 years. During that time we have developed a company that has supported all the major stakeholders within high-value and pharmaceutical logistics, providing services such as Supply Chain Vulnerability Assessments, GDP Audits/Health Checks and Supply Chain Security Audits. We have also project managed the implementation of a global QMS for a 3PL, developed our own classroom and online training courses such as,  ‘GDP for Logistics‘ and ‘Falsified Medicines & Supply Chain Security’ specifically aimed at the Logistics Industries, and supported airlines and 3PLs in obtaining their WDAs amongst many other projects. We have been fortunate enough to have amazing Associates, such as Tom Cochrane, whose experience and knowledge have strengthened our team, and developed some great partnerships.

This will be my last week with ASC as I have been offered an incredibly exciting opportunity which will be announced publicly very soon. Henry Moran will continue to develop ASC, taking it from strength-to-strength, and will ensure ASC’s clients are well looked after. I know that ASC is in very capable hands.

I would like to take this opportunity to thank all those who have supported me and ASC over the past 8 years. I am staying within this industry, so don’t worry I won’t be going anywhere.

Keep an eye out for my new adventure announcement.

Amy ShortmanASC Amy Shortman CEO



On 19th/ 20th March 2019 in London, UK Corvus Global Events hosted the 2nd Annual Pharma Security World 2019 – Anti-Counterfeiting, Drug Serialization and Supply-Chain Conference, where Pharma industry experts shared various challenges faced, new strategies, case studies and use of innovative ideas and the conference will also offer opportunities to encourage partnerships and collaborations. ASC’s Tom Cochrane shared his 35+ years’ of experience on Supply Chain Security, the important of training those within the supply chain and focused in on the EU’s Falsified Medicine Directive andDrug Supply Chain Security Act (DSCSA)Tom Cochrane ASC Associate

‘The US is driving the path with the approved in 2013. DSCSA guide for end-to-end traceability is extended over a period of 10 years, with expectations sketched throughout the supply chain. The complete supply chain is relied upon to be electronically incorporated and all hubs of traceability to be built up by November 2023. The E.U.’s Falsified Medicines Directive requires drug companies to adopt mass serialization and other anti-counterfeiting measures starting in 2019. Manufacturers who operate in the E.U. will have to add unique identification numbers to the outer packaging of all prescription drugs, and equip containers with tamperproof seals. To guide customers from illicit online drug stores that supply fake medications, the FMD requires approved legitimate Internet drug stores to show a logo distinguishing them as E.U. approved drug retailers.’

The Conference deliberations were on the following themes:

• Understanding and meeting the needs of DSCSA, EU FMD and other global regulations
• Synchrony of the Pharma Industry and professional bodies against counterfeiting
• Tackling pharmaceutical crime – initiatives at multinational, EU and national level
• IP and regulatory enforcement
• Strategies for public awareness and patient protection
• Best practices to protect your brand
• The role of the Internet in aiding the counterfeiters – How to overcome the situation?
• Common Logo initiative in the EU for online pharmacies
• Brand Protection & Securing supply chain integrity
• End to End supply chain visibility
• Developing a sustainable Serialization strategy
• Global enterprise level solutions for anti-counterfeiting
• Integration of track & trace solutions in production and supply chain
• Smart Packaging, Labeling, Artwork, Warehouse & Logistics
• Effective Authentication Technologies
• Best selection of tamper-evident features
• Developing a RMP for your supply chain to protect your Brand, Product and Patient Safety
• Measuring the Effectiveness of a Good Quality System through frequent external and internal audits
• Debating the use and implementation of serialization, barcoding, and RFID
• Serialization Data and Analytics driven approach to increase supply chain agility
• Cloud-based technology complement big data solutions in monitoring and improving supply chain processes
• The need to understand and adopt new technologies like IoT, Analytics, Block chain, Machine Learning and Artificial Intelligence
• Case study: How companies are structuring their counterfeiting efforts and departments?